dasatinib
NDC 70710-1745, dasatinib, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1745
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218719
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1745 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB100 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1745-3 | 70710174503 | 30 TABLET in 1 BOTTLE (70710-1745-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/11703145-29ea-480a-9810-bc70663b783fNADAC price for package 70710174503
GET /v1/drugs/nadac/70710174503
Use it
Look up 70710-1745 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1745 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1745. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.